Skip to main content
. 2020 May;12(5):2706–2712. doi: 10.21037/jtd.2020.04.30

Table 3. Relationship between immune-related adverse events and response to treatment.

irAE All patients, N (%) PD + SD, N (%) PR, N (%) P value
None 48 (49.5) 37 (77.1) 11 (22.9)         1.000
Any grade* 48 (49.5) 37 (77.1) 11 (22.9)
Grade
   <3 90 (92.8) 72 (80.0) 18 (20.0)         0.023
   ≥3* 6 (6.2) 2 (33.3) 4 (67.7)

*, response was non-evaluable in one patient and was excluded from response analysis. irAE, immune-related adverse event; PD, progressive disease; SD, stable disease; PR, partial response.